CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN

被引：70
作者：
CORDEN, BJ
FINE, RL
OZOLS, RF
COLLINS, JM
机构：
[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BLDG 10,ROOM 6N119,BETHESDA,MD 20205
[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20205
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF00552723
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 41
页数：4
相关论文
共 15 条
[1]  
BELT RJ, 1979, CANCER TREAT REP, V63, P1515
[2]  
CHARY KK, 1977, CANCER TREAT REP, V61, P367
[3]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[4]  
GORMLEY PE, 1979, CLIN PHARMACOL THER, V25, P351
[5]   STABILITY OF CISPLATIN IN AQUEOUS-SOLUTION [J].
GREENE, RF ;
CHATTERJI, DC ;
HIRANAKA, PK ;
GALLELLI, JF .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01) :38-43
[6]   CLINICAL KINETICS OF INTACT CISPLATIN AND SOME RELATED SPECIES [J].
HIMMELSTEIN, KJ ;
PATTON, TF ;
BELT, RJ ;
TAYLOR, S ;
REPTA, AJ ;
STERNSON, LA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :658-664
[7]   CIRCADIAN TIME-DEPENDENCE OF CISPLATIN URINARY KINETICS [J].
HRUSHESKY, WJM ;
BORCH, R ;
LEVI, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :330-339
[8]  
JACOBS C, 1980, CANCER TREAT REP, V64, P1223
[9]   ANALYSIS OF PLATINUM IN BIOLOGICAL-MATERIALS BY FLAMELESS ATOMIC-ABSORPTION SPECTROPHOTOMETRY [J].
LEROY, AF ;
WEHLING, ML ;
SPONSELLER, HL ;
FRIAUF, WS ;
SOLOMON, RE ;
DEDRICK, RL ;
LITTERST, CL ;
GRAM, TE ;
GUARINO, AM ;
BECKER, DA .
BIOCHEMICAL MEDICINE, 1977, 18 (02) :184-191
[10]   PLATINUM NEPHROTOXICITY [J].
MADIAS, NE ;
HARRINGTON, JT .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (02) :307-314
12